BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34032594)

  • 1. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles.
    Hong Z; Tian C; Stewart T; Aro P; Soltys D; Bercow M; Sheng L; Borden K; Khrisat T; Pan C; Zabetian CP; Peskind ER; Quinn JF; Montine TJ; Aasly J; Shi M; Zhang J
    Neurology; 2021 May; 96(18):e2332-e2345. PubMed ID: 34032594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis.
    Wang P; Lan G; Xu B; Yu Z; Tian C; Lei X; Meissner WG; Feng T; Yang Y; Zhang J
    Transl Neurodegener; 2023 Aug; 12(1):40. PubMed ID: 37620916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
    Chahine LM; Beach TG; Brumm MC; Adler CH; Coffey CS; Mosovsky S; Caspell-Garcia C; Serrano GE; Munoz DG; White CL; Crary JF; Jennings D; Taylor P; Foroud T; Arnedo V; Kopil CM; Riley L; Dave KD; Mollenhauer B;
    Neurology; 2020 Sep; 95(9):e1267-e1284. PubMed ID: 32747521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
    Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
    Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice.
    Huang Y; Liu Z; Li N; Tian C; Yang H; Huo Y; Li Y; Zhang J; Yu Z
    Ann Neurol; 2022 Aug; 92(2):230-245. PubMed ID: 35596947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease.
    Liu Z; Chan RB; Cai Z; Liu X; Wu Y; Yu Z; Feng T; Yang Y; Zhang J
    J Neuroinflammation; 2022 Feb; 19(1):53. PubMed ID: 35193594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.
    Lööv C; Scherzer CR; Hyman BT; Breakefield XO; Ingelsson M
    Cell Mol Neurobiol; 2016 Apr; 36(3):437-48. PubMed ID: 26993503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
    Agliardi C; Meloni M; Guerini FR; Zanzottera M; Bolognesi E; Baglio F; Clerici M
    Neurobiol Dis; 2021 Jan; 148():105185. PubMed ID: 33217562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.
    Zhang S; Eitan E; Wu TY; Mattson MP
    Neurobiol Aging; 2018 Jan; 61():52-65. PubMed ID: 29035751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease.
    von Euler Chelpin M; Söderberg L; Fälting J; Möller C; Giorgetti M; Constantinescu R; Blennow K; Zetterberg H; Höglund K
    J Parkinsons Dis; 2020; 10(4):1429-1442. PubMed ID: 33016895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
    Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
    J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
    Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
    Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression.
    Yang L; Stewart T; Shi M; Pottiez G; Dator R; Wu R; Aro P; Schuster RJ; Ginghina C; Pan C; Gao Y; Qian W; Zabetian CP; Hu SC; Quinn JF; Zhang J
    Proteomics Clin Appl; 2017 Jul; 11(7-8):. PubMed ID: 28319654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Alpha-Synuclein is Essential for the Transfer of Pathology by Exosome-Enriched Extracellular Vesicles, Following Inoculation with Preformed Fibrils in vivo.
    Melachroinou K; Divolis G; Tsafaras G; Karampetsou M; Fortis S; Stratoulias Y; Papadopoulou G; Kriebardis AG; Samiotaki M; Vekrellis K
    Aging Dis; 2024 Apr; 15(2):869-892. PubMed ID: 37548944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent.
    Bagchi DP; Yu L; Perlmutter JS; Xu J; Mach RH; Tu Z; Kotzbauer PT
    PLoS One; 2013; 8(2):e55031. PubMed ID: 23405108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
    Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
    Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
    Taha HB; Ati SS
    CNS Neurosci Ther; 2023 Dec; 29(12):3741-3755. PubMed ID: 37416941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
    Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
    Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.